Top compounds associated with response to OPN1LW


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.016 0.7
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA AT13387 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA CIL70 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA cediranib CTRPv2 pan-cancer AAC 0.019 0.7
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.012 0.7
mRNA SKI-II CTRPv2 pan-cancer AAC -0.012 0.7
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
Download CSV